Learn
Familial Hypercholesterolemia: Why Current Screening Guidelines Are Missing Most Cases
Familial hypercholesterolemia affects approximately 1 in 200 people, is highly treatable, and passes silently through families for generations. A new study of more than 84,000 participants found that standard clinical criteria identified fewer than one in three confirmed cases. Here is what that means for cardiovascular risk assessment.
The Clinician's Role in Genomic Medicine: Why Trust Is the Foundation
As genomic testing moves into routine care across reproductive health, cardiovascular risk, and cancer prevention, a new systematic review makes one thing clear: patients look to their clinician first. How that conversation goes determines whether testing leads to meaningful health outcomes or confusion.
Precision Prostate Cancer Screening: Moving From One-Size-Fits-All to Risk Stratified Prevention
Recent studies show that genomic risk modelling can refine prostate cancer screening by combining polygenic risk scores, family history, and genetic ancestry. This risk stratified approach enables more precise identification of individuals at higher risk while reducing unnecessary testing for lower-risk patients.
Defining Boundaries in Genomic Newborn Screening: Consent, Actionability, and Long‑Term Stewardship
Genomic sequencing in newborn screening can detect rare but treatable childhood conditions before symptoms appear, enabling timely interventions. By combining structured reporting with integrated genetic counselling, findings can be translated into actionable care. This approach helps ensure that early detection leads to meaningful outcomes while minimizing uncertainty or unnecessary surveillance.
From Eligibility Criteria to Preventive Insight: The Expanding Role of Population Genomics
A pilot population genomic screening program in Australia revealed that nearly 2% of young adults carry pathogenic variants missed by traditional guidelines. Structured interpretation, reporting, and counselling help ensure early, preventive care for at-risk individuals.
Do I need preventative genetic testing if I feel healthy?
Feeling healthy doesn’t always mean you’re free from genetic risk. Many inherited conditions remain silent for years: 6% of people carry gene changes that could significantly impact their cancer or heart health without showing any symptoms. Preventative genetic testing isn’t about diagnosing illness; it’s about giving you clarity early, so you can take proactive steps to protect your long-term health. Even if your blood tests are normal, and you live a healthy lifestyle, understanding your inherited risks can help you stay one step ahead, and give peace of mind for you and your family.
Unlocking hidden health risks: How Jess took control with preventative genetic testing
Even if you feel healthy, your genes may tell a different story. Jess, an active and health-conscious woman, discovered through Eugene’s Preventative Health Test that she carries a genetic variant linked to heart disease. By understanding her genetic risks early, she took proactive steps to protect her heart, and her family. Learn how preventative genetic testing can uncover hidden health risks and empower you to act before symptoms appear.
Genetic discrimination by life insurers soon to be banned: Implications for Healthcare
Australia’s new legislation banning genetic discrimination by life insurers removes a long-standing barrier to genetic testing and preventive care. By separating clinical insight from insurance risk, the reform supports earlier screening, informed decision-making, and better health outcomes. For healthcare providers, it enables more confident, patient-centred integration of genetics into everyday care pathways.
BabyScreen+ : How Genomic Newborn Screening is Shaping Prevention-Focused Paediatric Care
The BabyScreen+ study shows how genomic newborn screening can extend standard programs to detect actionable conditions that may otherwise be missed. When supported by genetic counselling and scalable digital models, early genomic insight enables timely intervention, personalised care planning, and a shift toward prevention-focused paediatric care.
